flow trial semaglutide kidney outcomes 2024 nejm hazard ratio 0.76 FLOW- the Visual Abstract — NephJC Treatment with sodium–glucose cotransporter 2 – Chronic Kidney Disease | Ozempic®

"A brand new effective pill for weight loss gives people greater flexibility to choose a GLP-1 treatment that can fit in their daily routine and preferences." Wegovy pill is only approved in the US

Strive vs smaller compounding pharmacies Smaller, local compounding pharmacies may also offer tirzepatide formulations

While GLP-1 receptor agonists have not been linked to dermatologic adverse events in clinical trials, many patients have reported acne vulgaris breakouts on social media after starting these medications, Tolkachjov and colleagues wrote

Albiglutide for the treatment of type 2 diabetes mellitus

Nausea affects roughly 15 to 20 percent of people at this dose, usually appearing within a few hours of injection and lasting 24 to 48 hours